Category Archives: Recent Media
New CellerateRX Quarter 3 2011 Newsletter Available for Download
The newest Quarterly Newsletter was released today. The four-page newsletter discusses the clinical and business aspects relating to our events in Quarter 3, 2011: Click here to read the newsletter on celleraterx.com Expanding CellerateRX Marketing Efforts Read about the new … Continue reading
PDF Treating Diabetic Ulcers with CellerateRX AdvaMed 2011 Video Interview
Stock News Now, a website which offers micro-cap video press releases and similar news interviewed Deborah Jenkins-Hutchinson at Advamed 2011: The Medtech Conference. In this interview, Deborah Hutchinson discusses the distribution of CellerateRX and how it helps patients with diabetic … Continue reading
OneMedRadio Discusses and Interviews Wound Management Technologies, Inc
OneMedRadio recently discussed Wound Management Technologies’ role in advanced wound care on their radio show. The interview has been posted and also transcribed on the OneMed website. Check it out today! Wound Management Proves Strong Potential With Distribution Agreements In … Continue reading
Proactive Investors Covers of Wound Management Technologies, Inc
Read our recent coverage that was posted online! Wound Management Technologies: CellerateRX® “ought to be standard issue in every hospital” Link to story: http://www.proactiveinvestors.com/companies/news/19595/wound-management-technologies-celleraterx-ought-to-be-standard-issue-in-every-hospital-19595.html Print PDF
NEAA Venture Research Issues Update Report on Wound Management Technologies, Inc.
NEAA Venutre Research, LLC issued a report on 7/13/11 about Wound Management Technologies, Inc, upgrading their recommendation to “Speculative BUY” due to major announced sales contracts. The full NEAA press release: http://www.marketwatch.com/story/neaa-venture-research-issues-update-report-on-wound-management-technologies-inc-2011-07-13?reflink=MW_news_stmp The full PDF report: http://neaaventure.com/wp-content/uploads/2011/07/WNDM_7.13.11.pdf Print PDF
WNDM President Interviewed by CEOCFOinterview.com
With FDA Approval for Most Wound Types and Medicare Reimbursement for their CellerateRX® Product, Wound Management Technologies, Inc. is in Position to Build on the Revenue Growth of 2010 that Tripled 2009 Numbers Wound Management Technologies’ Deborah Jenkins Hutchinson … Continue reading
Drug Topics Newsmagazine OTC foot-care products
CellerateRX is highlighted as a collagen based foot-care aid in this news article in over the counter options to prevent problems or to soothe already aching feet. Click Here to read more: Print PDF
CellerateRX on Television | Evening News
(YouTube Video – Mobile Enabled) CellerateRX®, a unique, patented activated collagen product was featured as part of a news special which was recently broadcast on network television. The special was part of a series focused on how the use of the … Continue reading
WNDM quoted in NEAA Press Release about New Dallas Chapter
The National Eagles and Angels Association (NEAA), a nationwide alliance of qualified individual investors and business angels, today reported that its newly formed Dallas Chapter was officially launched on March 8, 2011, welcoming over 40 new founding members to the … Continue reading
CellerateRX promoted by TVGoods
The TVGoods Facebook posted a video promoting CellerateRx. TV Goods is doing a TV spot campaign on 28g CellerateRX gel with our distributor Med3TV. Take two minutes and watch the TV spot: Click to Watch Print PDF
